搜索
1

1

News Center
Homepage
/
Milestones
/
2019.4

2019.4

  • Time of issue:2022-02-21
  • Views:

(Summary description)Establishment of Nanobody and Recombinant Antibody Platform

2019.4

(Summary description)Establishment of Nanobody and Recombinant Antibody Platform

  • Categories:Milestones
  • Author:
  • Origin:
  • Time of issue:2022-02-21 17:49
  • Views:
Information

建立纳米抗体及重组抗体平台

Previous: 2020.7
Next: 2018.5
Previous: 2020.7
Next: 2018.5

Related news

Other CDMO Services 2023-06-13 17:58:12
In addition to providing custom development of raw materials and reagents, AIVD Biotech's CDMO services also include other services such as LDTs (Lab Development Tests), Global Registration, Global Quality Management System, Clinical Trials, Supply Chain Management and Mass Production, Circulation Sales, and Registrant System.
CDMO Custom Development of Test Kits 2023-06-13 17:21:25
AIVD Biotech's CDMO custom development of test kits services include the following eight major development platforms and four technical trainings.
What SARS-CoV-2 Changes in Your Body's Architecture 2023-04-13 16:55:34
This study not only helps to explain the immunological symptoms of SARS-CoV-2 infection in humans, but also explains the cause of "Long COVID-19".
Collection and preservation of IVD test samples 2023-04-03 16:27:12

Shenzhen AIVD Biotechnology Co. , LTD.

A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China

E-mail： market@aivdbiotech.com  
             info@aivdbiotech.com

Tel： +86-755-26165742   +86 18543132823

WhatsApp：+86 18543132823

facebook facebook facebook facebook facebook

© 2022 Shenzhen AIVD Biotechnology Co.,LTD.      粤ICP备18093805号